Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories

被引：13

作者：

Freydiere, AM

Perry, JD

Faure, O

Willinger, B

Tortorano, AM

Nicholson, A

Peman, J

Verweij, PE

机构：

[1] Hop Debrousse, Hosp Civils Lyon, Bacteriol Lab, F-69322 Lyon 05, France

[2] Ctr Hosp Univ, Grenoble, France

[3] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England

[4] Med Univ Vienna, Div Clin Microbiol, Inst Med Microbiol & Hyg, Vienna, Austria

[5] Univ Milan, Milan, Italy

[6] Univ Valencia, Hosp La Fe, Valencia, Spain

[7] Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2004年 / 42卷 / 10期

关键词：

D O I：

10.1128/JCM.42.10.4870-4872.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

When evaluated in six clinical laboratories from six countries with 1,174 fresh isolates, including 715 Candida glabrata and 459 non-C. glabrata strains, GLABRATA RTT (Fumouze Diagnostics, Levallois Perret, France) yielded an overall sensitivity and an overall specificity of 95.8 and 98.9%, respectively. The results were consistent from one laboratory to another. The five false-positive results corresponded to C. parapsilosis (n = 2), C. tropicalis, C. guilliermondii, and C. lusitaniae. GLABRATA RTT allows a rapid, cost-effective, and reliable presumptive identification of C. glabrata.

引用

收藏

页码：4870 / 4872

页数：3

相关论文

共 21 条

[1] Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates [J].

Baumgartner, C ;

Freydiere, AM ;

Gille, Y .

JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (02) :454-456

[2] Global distribution and outcomes for Candida species causing invasive candidiasis:: Results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis [J].

Colombo, AL ;

Perfect, J ;

DiNubile, M ;

Bartizal, K ;

Motyl, M ;

Hicks, P ;

Lupinacci, R ;

Sable, C ;

Kartsonis, N .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (08) :470-474

[3] Comparison of four methodologies for rapid and cost-effective identification of Candida glabrata [J].

Fenn, JP ;

Billetdeaux, E ;

Segal, H ;

Skodack-Jones, L ;

Padilla, PE ;

Bale, M ;

Carroll, K .

JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (10) :3387-3389

[4] Candida glabrata:: Review of epidemiology, pathogenesis, and clinical disease with comparison to C-albicans [J].

Fidel, PL ;

Vazquez, JA ;

Sobel, JD .

CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (01) :80-+

[5] Rapid identification of Candida glabrata with a new commercial test, GLABRATA RTT [J].

Freydiere, AM ;

Robert, R ;

Ploton, C ;

Marot-Leblond, A ;

Monerau, F ;

Vandenesch, F .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) :3861-3863

[6] Identification of Candida glabrata by a 30-second trehalase test [J].

Freydière, AM ;

Parant, F ;

Noel-Baron, F ;

Crepy, M ;

Treny, A ;

Raberin, H ;

Davidson, A ;

Odds, FC .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) :3602-3605

[7] Yeast identification in the clinical microbiology accepted 15 August 2000 laboratory: phenotypical methods [J].

Freydiere, AM ;

Guinet, R ;

Boiron, P .

MEDICAL MYCOLOGY, 2001, 39 (01) :9-33

[8]

Freydiere AM, 1996, J CLIN MICROBIOL, V34, P2048, DOI 10.1128/JCM.34.8.2048-2048.1996

[9] Evaluation of candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species [J].

Fricker-Hidalgo, H ;

Orenga, S ;

Lebeau, B ;

Pelloux, H ;

Brenier-Pinchart, MP ;

Ambroise-Thomas, P ;

Grillot, R .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1647-1649

[10] Screening protocol for Torulopsis (Candida) glabrata [J].

Land, G ;

Burke, J ;

Shelby, C ;

Rhodes, J ;

Collett, J ;

Bennett, I ;

Johnson, J .

JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (09) :2300-2303